The role of MicroRNAs expression in laryngeal cancer

Oncotarget

Volumn 6, Issue 27, 2015, Pages 23297-23305

  Yu, Xin ^a   Li, Zheng ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Laryngeal cancer; MiRNAs; Oncogene; Tumor suppressor gene

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 106B 3P; MICRORNA 10A 5P; MICRORNA 125A 5P; MICRORNA 125B; MICRORNA 1287; MICRORNA 1303; MICRORNA 143; MICRORNA 144 3P; MICRORNA 145; MICRORNA 16; MICRORNA 192; MICRORNA 195 5P; MICRORNA 203; MICRORNA 205; MICRORNA 21; MICRORNA 21 3P; MICRORNA 212 3P; MICRORNA 331 3P; MICRORNA 409; MICRORNA 603; MICRORNA 634; MICRORNA 657; MICRORNA 660 5P; MICRORNA 708; MICRORNA 93; PACLITAXEL; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG; UNINDEXED DRUG; TUMOR MARKER;

ADVANCED CANCER; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CELL CYCLE ARREST; CELL PROLIFERATION; DISEASE MARKER; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; HUMAN; LARYNX CANCER; MICROARRAY ANALYSIS; NONHUMAN; PATHOGENESIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR INVASION; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; LARYNX TUMOR; METABOLISM; METASTASIS; MOUSE; PROGNOSIS; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ANIMALS; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; LARYNGEAL NEOPLASMS; MICE; MICE, INBRED BALB C; MICRORNAS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS;

EID: 84943405068     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4195     Document Type: Article

References (91)

1. Yu X, Li Z, Liu J. MiRNAs in primary cutaneous lymphomas. Cell Prolif. 2015;48:271-7.
2. Yu X, Li Z. MicroRNAs regulate vascular smooth muscle cell functions in atherosclerosis (review). Int J Mol Med. 2014;34:923-933.
3. Gargalionis AN, Basdra EK. Insights in microRNAs biology. Curr Top Med Chem. 2013;13:1493-1502.
4. Hata A. Functions of microRNAs in cardiovascular biology and disease. Annu Rev Physiol. 2013;75:69-93.
5. Karp X, Ambros V. Developmental biology. Encountering microRNAs in cell fate signaling. Science. 2005; 310:1288-1289.
6. Latronico MV, Catalucci D, Condorelli G. Emerging role of microRNAs in cardiovascular biology. Circ Res. 2007; 101:1225-1236.
7. Weidhaas J. Using microRNAs to understand cancer biology. Lancet Oncol. 2010;11:106-107.
8. Li Z, Yu X, Shen J, Jiang Y. MicroRNA dysregulation in uveal melanoma:a new player enters the game. Oncotarget. 2015;6:4562-8.
9. Li Z, Yu X, Shen J, Wu WK, Chan MT. MicroRNA expression and its clinical implications in Ewing's sarcoma. Cell Prolif. 2015;48:1-6.
10. Li Z, Yu X, Wang Y, Shen J, Wu WK, et al. By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth. Oncotarget. 2014.
11. Bezan A, Gerger A, Pichler M. MicroRNAs in testicular cancer:implications for pathogenesis, diagnosis, prognosis and therapy. Anticancer Res. 2014;34:2709-2713.
12. Callegari E, Gramantieri L, Domenicali M, D'Abundo L, Sabbioni S, et al. MicroRNAs in liver cancer:a model for investigating pathogenesis and novel therapeutic approaches. Cell Death Differ. 2015;22:46-57.
13. Liu C, Tang DG. MicroRNA regulation of cancer stem cells. Cancer Res. 2011;71:5950-5954.
14. Lovat F, Valeri N, Croce CM. MicroRNAs in the pathogenesis of cancer. Semin Oncol. 2011;38:724-733.
15. Mayne GC, Hussey DJ, Watson DI. MicroRNAs and esophageal cancer-implications for pathogenesis and therapy. Curr Pharm Des. 2013;19:1211-1226.
16. Mezzanzanica D, Bagnoli M, De Cecco L, Valeri B, Canevari S. Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications. Int J Biochem Cell Biol. 2010;42:1262-1272.
17. Okayama H, Schetter AJ, Harris CC. MicroRNAs and inflammation in the pathogenesis and progression of colon cancer. Dig Dis. 2012;30:9-15.
18. Shah NR, Chen H. MicroRNAs in pathogenesis of breast cancer:Implications in diagnosis and treatment. World J Clin Oncol. 2014;5:48-60.
19. Sianou A, Galyfos G, Moragianni D, Andromidas P, Kaparos G, et al. The role of microRNAs in the pathogenesis of endometrial cancer:a systematic review. Arch Gynecol Obstet. 2015;292:271-82.
20. Su X, Xing J, Wang Z, Chen L, Cui M, et al. microRNAs and ceRNAs:RNA networks in pathogenesis of cancer. Chin J Cancer Res. 2013;25:235-239.
21. White NM, Yousef GM. MicroRNAs:exploring a new dimension in the pathogenesis of kidney cancer. BMC Med. 2010;8:65.
22. Burzynski NJ. A statistical review of oral-pharyngeal and laryngeal cancer in Kentucky from 1962 through 1966. J Ky Dent Assoc. 1969;21:13-20.
23. Galli J, Cammarota G, Volante M, De Corso E, Almadori G, et al. Laryngeal carcinoma and laryngo-pharyngeal reflux disease. Acta Otorhinolaryngol Ital. 2006;26:260-263.
24. Tomeh C, Holsinger FC. Laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg. 2014;22:147-153.
25. Voutilainen A, Tuovinen P. Treatment of laryngeal cancer and its results. A review of 261 cases. Ann Chir Gynaecol Fenn. 1962;51:14-26.
26. Hillman RE, Walsh MJ, Wolf GT, Fisher SG, Hong WK. Functional outcomes following treatment for advanced laryngeal cancer. Part I-Voice preservation in advanced laryngeal cancer. Part II-Laryngectomy rehabilitation:the state of the art in the VA System. Research Speech-Language Pathologists. Department of Veterans Affairs Laryngeal Cancer Study Group. Ann Otol Rhinol Laryngol. 1998;172:1-27.
27. Jenckel F, Knecht R. State of the art in the treatment of laryngeal cancer. Anticancer Res. 2013;33:4701-4710.
28. Fernandez-Hernando C, Suarez Y, Rayner KJ, Moore KJ. MicroRNAs in lipid metabolism. Curr Opin Lipidol. 2011; 22:86-92.
29. Kanellopoulou C, Monticelli S. A role for microRNAs in the development of the immune system and in the pathogenesis of cancer. Semin Cancer Biol. 2008;18:79-88.
30. Donzelli S, Strano S, Blandino G. microRNAs:short noncoding bullets of gain of function mutant p53 proteins. Oncoscience. 2014;1:427-433.
31. Sanchez-Diaz PC, Hsiao TH, Zou Y, Sugalski AJ, HeimHall J, et al. In silico functional analyses and discovery of survival-associated microRNA signatures in pediatric osteosarcoma. Oncoscience. 2014;1:599-608.
32. Hayes J, Thygesen H, Droop A, Hughes TA, Westhead D, et al. Prognostic microRNAs in high-grade glioma reveal a link to oligodendrocyte precursor differentiation. Oncoscience. 2015;2:252-262.
33. Li Z, Yu X, Shen J, Jiang Y. MicroRNA dysregulation in uveal melanoma:a new player enters the game. Oncotarget. 2015;6:4562-4568.
34. Xu CZ, Xie J, Jin B, Chen XW, Sun ZF, et al. Gene and microRNA expression reveals sensitivity to paclitaxel in laryngeal cancer cell line. Int J Clin Exp Pathol. 2013; 6:1351-1361.
35. Cao P, Zhou L, Zhang J, Zheng F, Wang H, et al. Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma. Head Neck. 2013;35:720-728.
36. Nohata N, Hanazawa T, Kinoshita T, Inamine A, Kikkawa N, et al. Tumour-suppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma. Br J Cancer. 2013;108:1648-1658.
37. Lu ZM, Lin YF, Jiang L, Chen LS, Luo XN, et al. Microribonucleic acid expression profiling and bioinformatic target gene analyses in laryngeal carcinoma. Onco Targets Ther. 2014;7:525-533.
38. Wang Y, Chen M, Tao Z, Hua Q, Chen S, et al. Identification of predictive biomarkers for early diagnosis of larynx carcinoma based on microRNA expression data. Cancer Genet. 2013;206:340-346.
39. Saito K, Inagaki K, Kamimoto T, Ito Y, Sugita T, et al. MicroRNA-196a is a putative diagnostic biomarker and therapeutic target for laryngeal cancer. PLoS One. 2013;8:e71480.
40. Tai J, Xiao X, Huang ZG, Yu ZK, Chen XH, et al. [MicroRNAs regulate epithelial-mesenchymal transition of supraglottic laryngeal cancer]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2013;48:499-503.
41. Ayaz L, Gorur A, Yaroglu HY, Ozcan C, Tamer L. Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma:potential earlydetection markers for laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol. 2013;139:1499-1506.
42. Wu H, Liu T, Wang R, Tian S, Liu M, et al. MicroRNA-16 targets zyxin and promotes cell motility in human laryngeal carcinoma cell line HEp-2. IUBMB Life. 2011;63:101-108.
43. Wu TY, Zhang TH, Qu LM, Feng JP, Tian LL, et al. MiR-19a is correlated with prognosis and apoptosis of laryngeal squamous cell carcinoma by regulating TIMP-2 expression. Int J Clin Exp Pathol. 2014;7:56-63.
44. Hu A, Huang JJ, Xu WH, Jin XJ, Li JP, et al. miR-21 and miR-375 microRNAs as candidate diagnostic biomarkers in squamous cell carcinoma of the larynx:association with patient survival. Am J Transl Res. 2014;6:604-613.
45. Yu X, Wu Y, Liu Y, Deng H, Shen Z, et al. miR-21, miR-106b and miR-375 as novel potential biomarkers for laryngeal squamous cell carcinoma. Curr Pharm Biotechnol. 2014;15:503-508.
46. Liu J, Lei DP, Jin T, Zhao XN, Li G, et al. Altered expression of miR-21 and PTEN in human laryngeal and hypopharyngeal squamous cell carcinomas. Asian Pac J Cancer Prev. 2011;12:2653-2657.
47. Ren J, Zhu D, Liu M, Sun Y, Tian L. Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of Laryngeal squamous cell carcinoma. Eur J Cancer. 2010;46:3409-3416.
48. Tian Y, Fu S, Qiu GB, Xu ZM, Liu N, et al. MicroRNA-27a promotes proliferation and suppresses apoptosis by targeting PLK2 in laryngeal carcinoma. BMC Cancer. 2014;14:678.
49. Xu Y, Wang K, Gao W, Zhang C, Huang F, et al. MicroRNA-106b regulates the tumor suppressor RUNX3 in laryngeal carcinoma cells. FEBS Lett. 2013; 587:3166-3174.
50. Li M, Tian L, Wang L, Yao H, Zhang J, et al. Downregulation of miR-129-5p inhibits growth and induces apoptosis in laryngeal squamous cell carcinoma by targeting APC. PLoS One. 2013;8:e77829.
51. Zhao XD, Zhang W, Liang HJ, Ji WY. Overexpression of miR-155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3. PLoS One. 2013;8:e56395.
52. Li X, Wang HL, Peng X, Zhou HF, Wang X. miR-1297 mediates PTEN expression and contributes to cell progression in LSCC. Biochem Biophys Res Commun. 2012; 427:254-260.
53. Chen P, Wang BL, Pan BS, Guo W. MiR-1297 regulates the growth, migration and invasion of colorectal cancer cells by targeting cyclo-oxygenase-2. Asian Pac J Cancer Prev. 2014;15:9185-9190.
54. Wang F, Song G, Liu M, Li X, Tang H. miRNA-1 targets fibronectin1 and suppresses the migration and invasion of the HEp2 laryngeal squamous carcinoma cell line. FEBS Lett. 2011;585:3263-3269.
55. Guo Y, Fu W, Chen H, Shang C, Zhong M. miR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein. Oncol Rep. 2012;27:1097-1103.
56. Li L, Wang B. Overexpression of microRNA-30b improves adenovirus-mediated p53 cancer gene therapy for laryngeal carcinoma. Int J Mol Sci. 2014;15:19729-19740.
57. Li W, Ma H, Sun J. MicroRNA34a/c function as tumor suppressors in Hep2 laryngeal carcinoma cells and may reduce GALNT7 expression. Mol Med Rep. 2014;9:1293-1298.
58. Cai KM, Bao XL, Kong XH, Jinag W, Mao MR, et al. HsamiR-34c suppresses growth and invasion of human laryngeal carcinoma cells via targeting c-Met. Int J Mol Med. 2010;25:565-571.
59. Luo HN, Wang ZH, Sheng Y, Zhang Q, Yan J, et al. MiR-139 targets CXCR4 and inhibits the proliferation and metastasis of laryngeal squamous carcinoma cells. Med Oncol. 2014;31:789.
60. Tian L, Li M, Ge J, Guo Y, Sun Y, et al. MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours. Tumour Biol. 2014;35:5953-5963.
61. Li S, Li Y, Wen Z, Kong F, Guan X, et al. microRNA-206 overexpression inhibits cellular proliferation and invasion of estrogen receptor alpha-positive ovarian cancer cells. Mol Med Rep. 2014;9:1703-1708.
62. Li M, Chen SM, Chen C, Zhang ZX, Dai MY, et al. microRNA2993p inhibits laryngeal cancer cell growth by targeting human telomerase reverse transcriptase mRNA. Mol Med Rep. 2015;11:4645-9.
63. Yungang W, Xiaoyu L, Pang T, Wenming L, Pan X. miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC). Biomed Pharmacother. 2014;68:149-154.
64. Shen Z, Zhan G, Deng H, Ren Y, Ye D, et al. MicroRNA-519a demonstrates significant tumour suppressive activity in laryngeal squamous cells by targeting anti-carcinoma HuR gene. J Laryngol Otol. 2013;127:1194-1202.
65. Chen WS, Leung CM, Pan HW, Hu LY, Li SC, et al. Silencing of miR-1-1 and miR-133a-2 cluster expression by DNA hypermethylation in colorectal cancer. Oncol Rep. 2012;28:1069-1076.
66. Diao Y, Guo X, Jiang L, Wang G, Zhang C, et al. miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma. J Biol Chem. 2014;289:529-539.
67. Huang YW, Kuo CT, Chen JH, Goodfellow PJ, Huang TH, et al. Hypermethylation of miR-203 in endometrial carcinomas. Gynecol Oncol. 2014;133:340-345.
68. Javeri A, Ghaffarpour M, Taha MF, Houshmand M. Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis. Med Oncol. 2013; 30:413.
69. Tsai KW, Liao YL, Wu CW, Hu LY, Li SC, et al. Aberrant hypermethylation of miR-9 genes in gastric cancer. Epigenetics. 2011;6:1189-1197.
70. Tsuruta T, Kozaki K, Uesugi A, Furuta M, Hirasawa A, et al. miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer. Cancer Res. 2011;71:6450-6462.
71. Xu L, Wang F, Xu XF, Mo WH, Xia YJ, et al. Downregulation of miR-212 expression by DNA hypermethylation in human gastric cancer cells. Med Oncol. 2011; 28:S189-196.
72. Andl T, Murchison EP, Liu F, Zhang Y, Yunta-Gonzalez M, et al. The miRNA-processing enzyme dicer is essential for the morphogenesis and maintenance of hair follicles. Curr Biol. 2006;16:1041-1049.
73. Frederikse PH, Donnelly R, Partyka LM. miRNA and Dicer in the mammalian lens:expression of brain-specific miRNAs in the lens. Histochem Cell Biol. 2006;126:1-8.
74. Lee YS, Nakahara K, Pham JW, Kim K, He Z, et al. Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways. Cell. 2004; 117:69-81.
75. Chen JC, Su YH, Chiu CF, Chang YW, Yu YH, et al. Suppression of Dicer increases sensitivity to gefitinib in human lung cancer cells. Ann Surg Oncol. 2014; 21:S555-563.
76. Jafari N, Dogaheh HP, Bohlooli S, Oyong GG, Shirzad Z, et al. Expression levels of microRNA machinery components Drosha, Dicer and DGCR8 in human (AGS, HepG2, and KEYSE-30) cancer cell lines. Int J Clin Exp Med. 2013; 6:269-274.
77. Faggad A, Kasajima A, Weichert W, Stenzinger A, Elwali NE, et al. Down-regulation of the microRNA processing enzyme Dicer is a prognostic factor in human colorectal cancer. Histopathology. 2012;61:552-561.
78. Selever J, Gu G, Lewis MT, Beyer A, Herynk MH, et al. Dicer-mediated upregulation of BCRP confers tamoxifen resistance in human breast cancer cells. Clin Cancer Res. 2011;17:6510-6521.
79. Ting AH, Suzuki H, Cope L, Schuebel KE, Lee BH, et al. A requirement for DICER to maintain full promoter CpG island hypermethylation in human cancer cells. Cancer Res. 2008;68:2570-2575.
80. Gao C, Li X, Tong B, Wu K, Liu Y, et al. Up-regulated expression of Dicer reveals poor prognosis in laryngeal squamous cell carcinoma. Acta Otolaryngol. 2014; 134:959-963.
81. Langevin SM, Stone RA, Bunker CH, Lyons-Weiler MA, LaFramboise WA, et al. MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck. Cancer. 2011;117:1454-1462.
82. Johnston N, Yan JC, Hoekzema CR, Samuels TL, Stoner GD, et al. Pepsin promotes proliferation of laryngeal and pharyngeal epithelial cells. Laryngoscope. 2012; 122:1317-1325.
83. Choe MH, Min JW, Jeon HB, Cho DH, Oh JS, et al. ERp57 modulates STAT3 activity in radioresistant laryngeal cancer cells and serves as a prognostic marker for laryngeal cancer. Oncotarget. 2015;6:2654-2666.
84. de Miguel-Luken MJ, Chaves-Conde M, de MiguelLuken V, Munoz-Galvan S, Lopez-Guerra JL, et al. MAP17 (PDZKIP1) as a novel prognostic biomarker for laryngeal cancer. Oncotarget. 2015;6:12625-36.
85. Sun X, Wang ZM, Song Y, Tai XH, Ji WY, et al. MicroRNA-126 modulates the tumor microenvironment by targeting calmodulin-regulated spectrin-associated protein 1 (Camsap1). Int J Oncol. 2014;44:1678-1684.
86. Shen Z, Zhan G, Ye D, Ren Y, Cheng L, et al. MicroRNA-34a affects the occurrence of laryngeal squamous cell carcinoma by targeting the antiapoptotic gene survivin. Med Oncol. 2012;29:2473-2480.
87. Bian K, Fan J, Zhang X, Yang XW, Zhu HY, et al. MicroRNA-203 leads to G1 phase cell cycle arrest in laryngeal carcinoma cells by directly targeting survivin. FEBS Lett. 2012;586:804-809.
88. Yin W, Wang P, Wang X, Song W, Cui X, et al. Identification of microRNAs and mRNAs associated with multidrug resistance of human laryngeal cancer Hep-2 cells. Braz J Med Biol Res. 2013;46:546-554.
89. Xu CZ, Shi RJ, Chen D, Sun YY, Wu QW, et al. Potential biomarkers for paclitaxel sensitivity in hypopharynx cancer cell. Int J Clin Exp Pathol. 2013;6:2745-2756.
90. Banno K, Iida M, Yanokura M, Kisu I, Iwata T, et al. MicroRNA in cervical cancer:OncomiRs and tumor suppressor miRs in diagnosis and treatment. ScientificWorldJournal. 2014;2014:178075.
91. Weiler J, Hunziker J, Hall J. Anti-miRNA oligonucleotides (AMOs):ammunition to target miRNAs implicated in human disease? Gene Ther. 2006;13:496-502.